For the first half of 2011, corporate venture funds comprised 12% of overall venture capital investment, up from 5.3% in 2010, according to PricewaterhouseCoopers and the National Venture Capital Association. Corporate venture funds were responsible for 25% of early-stage biotech financing in the first half of this year, versus 15% for all of last year. […]
This month, the FDA launched a DNA-barcode library for 250 fish species, which can be accessed by outside labs and the public. The library is the result of a collaboration with the Smithsonian Institution to standardize testing methods using DNA sequencing in order to combat seafood fraud. Popular seafood such as red snapper, wild salmon […]
EvaluatePharma predicts some shuffling of the list of the world’s top drug firms through 2016. The top spot, which Pfizer has held for nine years, will be usurped by Sanofi next year. Sanofi’s projected five-year compound annual growth rate (CAGR) of 4% should allow it to maintain first place through 2016. Novartis is expected to […]
Among the 1,000 global public companies that invested the most in R&D in fiscal 2010, R&D spending reached $550 billion. The amount is a 9.3% increase from fiscal 2009 and a 5.6% increase from fiscal 2008. Revenues for the top 1,000 companies grew 15% in FY10. The fastest growth rate in R&D spending belonged to […]
The EPA has announced it will set standards for wastewater discharges resulting from coalbed methane extraction and shale gas extraction and issue a proposed rule for each in 2013 and 2014, respectively. Shale gas extraction has grown to comprise nearly 15% of US natural gas production. Wastewater from such extractions cannot be directly discharged into […]
Critics of the FBI’s planned upgrade to its Codis system, which generates the individual genetic profiles stored in a national DNA database, shared their doubts at the Promega 22nd International Symposium on Human Identification earlier this month. The FBI has decided to increase the number of genetic markers, known as core loci, Codis uses to […]
Agricultural R&D is increasing after years of stagnation. As the price of food, measured in real terms, fell over the last 20 years, so did R&D investment. However, demand increased, leading to lower productivity. R&D is critical to address the growing scarcity of water, soil and other natural resources. DNA sequencing and bioinformatics are among […]
In September, the FDA provided Congress with its mandated report on the Food Emergency Response Network (FERN). The FDA said FERN will help it adhere to lab-related specifications in the Food Safety Modernization Act (FSMA). FERN unites US federal, state and local food-testing labs into a network able to handle food contamination emergencies. FERN manages […]
Global semiconductor capital equipment spending should reach $43.5 billion in 2011, a 7.1% increase from 2010, but will stall for the rest of this year and into next, dropping 19.2% to $35.2 billion in 2012. Gartner predicts that the capital spending decline will be due to too much electronics inventory and weak demand because of […]
The US has improved its response to public health emergencies, according to a Centers for Disease Control and Prevention (CDC) report released this month. State public health labs have strengthened their efforts in identifying and reporting disease-causing bacteria. In 2010, a total of 142 Laboratory Response Network (LRN) labs could test for biological agents, up […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

